Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease

Background: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypo...

Full description

Bibliographic Details
Main Authors: Priyanka Bhandari, Zeel Shah, Kush Patel, Ruchir Patel
Format: Article
Language:English
Published: Taylor & Francis Group 2019-09-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2019.1661148
id doaj-4664c65225cf4b4abae89aed01c71b98
record_format Article
spelling doaj-4664c65225cf4b4abae89aed01c71b982020-11-25T01:54:28ZengTaylor & Francis GroupJournal of Community Hospital Internal Medicine Perspectives2000-96662019-09-019540340910.1080/20009666.2019.16611481661148Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver diseasePriyanka Bhandari0Zeel Shah1Kush Patel2Ruchir Patel3Mount Sinai Elmhurst HospitalMount Sinai Elmhurst HospitalSouthside Northwell HospitalHenry Ford HospitalBackground: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypoperfusion. Methods: We performed a retrospective study of 544 consecutive cardiac catheterizations in ESLD patients from December 2003 to May 2013 to calculate the incidence of CIAKI post-coronary angiography and to identify risk factors for CIAKI. CIAKI was defined as a serum creatinine increase of either ≥ 25% or ≥ 0.5 mg/dL from baseline within 72 hours. Multivariable and Cox regression analysis was performed for development of CIAKI and all-cause mortality, respectively. Results: Overall, 179 cases of coronary angiography were included in the final analysis. CIAKI occurred in 23% of patients. All-cause mortality was 52% in the CIAKI group and 37% in the non-CIAKI group, with a mean follow-up of 2.2 ± 3.8 years. Multivariable analysis identified intensive care unit admission (OR 2.72, CI 1.05–7.01, p < 0.05) and baseline estimated glomerular filtration rate (OR 1.02, CI 1.002–1.035, p < 0.05) as independent predictors of CIAKI. Cox regression analysis identified pre-angiography beta-blocker use (HR 2.13, CI 1.04–4.38, p < 0.05), international normalized ratio (HR 1.37, CI 1.05–1.78, p < 0.05) and Mehran risk score (HR 1.13, CI 1.02–1.25, p < 0.05) as independent predictors of all-cause mortality. Conclusions: CIAKI in ESLD patients undergoing coronary angiography occurs at a moderately elevated rate when compared to the general population.http://dx.doi.org/10.1080/20009666.2019.1661148contrast-induced acute kidney injurycontrast nephropathycoronary angiographymortalityoutcomescirrhosisend-stage liver disease
collection DOAJ
language English
format Article
sources DOAJ
author Priyanka Bhandari
Zeel Shah
Kush Patel
Ruchir Patel
spellingShingle Priyanka Bhandari
Zeel Shah
Kush Patel
Ruchir Patel
Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
Journal of Community Hospital Internal Medicine Perspectives
contrast-induced acute kidney injury
contrast nephropathy
coronary angiography
mortality
outcomes
cirrhosis
end-stage liver disease
author_facet Priyanka Bhandari
Zeel Shah
Kush Patel
Ruchir Patel
author_sort Priyanka Bhandari
title Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
title_short Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
title_full Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
title_fullStr Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
title_full_unstemmed Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
title_sort contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease
publisher Taylor & Francis Group
series Journal of Community Hospital Internal Medicine Perspectives
issn 2000-9666
publishDate 2019-09-01
description Background: Contrast-induced acute kidney injury (CIAKI) following coronary angiography is frequently observed in the general population. End-stage liver disease (ESLD) patients are at a particularly increased risk for development of CIAKI following coronary angiography due to preexisting renal hypoperfusion. Methods: We performed a retrospective study of 544 consecutive cardiac catheterizations in ESLD patients from December 2003 to May 2013 to calculate the incidence of CIAKI post-coronary angiography and to identify risk factors for CIAKI. CIAKI was defined as a serum creatinine increase of either ≥ 25% or ≥ 0.5 mg/dL from baseline within 72 hours. Multivariable and Cox regression analysis was performed for development of CIAKI and all-cause mortality, respectively. Results: Overall, 179 cases of coronary angiography were included in the final analysis. CIAKI occurred in 23% of patients. All-cause mortality was 52% in the CIAKI group and 37% in the non-CIAKI group, with a mean follow-up of 2.2 ± 3.8 years. Multivariable analysis identified intensive care unit admission (OR 2.72, CI 1.05–7.01, p < 0.05) and baseline estimated glomerular filtration rate (OR 1.02, CI 1.002–1.035, p < 0.05) as independent predictors of CIAKI. Cox regression analysis identified pre-angiography beta-blocker use (HR 2.13, CI 1.04–4.38, p < 0.05), international normalized ratio (HR 1.37, CI 1.05–1.78, p < 0.05) and Mehran risk score (HR 1.13, CI 1.02–1.25, p < 0.05) as independent predictors of all-cause mortality. Conclusions: CIAKI in ESLD patients undergoing coronary angiography occurs at a moderately elevated rate when compared to the general population.
topic contrast-induced acute kidney injury
contrast nephropathy
coronary angiography
mortality
outcomes
cirrhosis
end-stage liver disease
url http://dx.doi.org/10.1080/20009666.2019.1661148
work_keys_str_mv AT priyankabhandari contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease
AT zeelshah contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease
AT kushpatel contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease
AT ruchirpatel contrastinducedacutekidneyinjuryfollowingcoronaryangiographyinpatientswithendstageliverdisease
_version_ 1724987246756495360